Skip to main content
Clinical Trials/JPRN-UMIN000039180
JPRN-UMIN000039180
Completed
N/A

A study to examine the effects of blood flow improvement and body temperature maintenance effects - A study to examine the effects of blood flow improvement and body temperature maintenance effects

Medicial Corporation Kenshokai, Fukushima Healthcare Center0 sites36 target enrollmentFebruary 1, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Healthy Individuals
Sponsor
Medicial Corporation Kenshokai, Fukushima Healthcare Center
Enrollment
36
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 1, 2020
End Date
January 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Medicial Corporation Kenshokai, Fukushima Healthcare Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • \[1]Those who are at risk of developing allergy in connection with research \[2]Those who have been diagnosed as underlying diseases associated with vascular disorders (obstructive arteriosclerosis, obstructive arteritis, collagen disease, diabetes etc.) \[3]Those who were judged inappropriate as subjects from the answers to the questionnaire \[4]Those who have a smoking habit \[5]Those who regularly use prescribed medicines (eg, warfarin, etc.) that may affect blood flow and skin surface temperature \[6]Those who take foods for specified health use or health foods that affect blood flow and skin surface temperature for three days or more per week \[7]Those already taking citrus drinks such as shikuwasa and oranges more than 3 days a week \[8]Those who were judged to have problems with research participation due to abnormalities in clinical laboratory values or cardiorespiratory functions \[9]Those who have a disease requiring continuous medication, those who have had a serious medical history requiring medication therapy \[10]Persons whose values of physical measurement values, physical examination values and clinical laboratory values before the start of ingestion are significantly deviated from the reference range \[11]Those who participate in other clinical research at the start of this research \[12]Others who judged that the researcher is inappropriate as the subject

Outcomes

Primary Outcomes

Not specified

Similar Trials